CSR and Sustainability in the News - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

CSR and Sustainability in the News
A roundup of developments in corporate social responsibility (CSR) and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.

PTSM: Pharmaceutical Technology Sourcing and Management
Volume 8, Issue 8

Merck & Co. and the Bill & Melinda Gates Foundation have formed a partnership to expand access to family planning, particularly in the developing world. Merck is pledging $25 million over eight years as part of its Merck for Mothers program, a 10-year initiative to reduce maternal mortality.

In other news, Merck & Co. has launched a three-year, $3-million initiative to support health departments in Atlanta, Houston, and Philadelphia, to enhance existing efforts and foster other innovative approaches to better serve people living with HIV/AIDS and prevent is further spread. The program supports the HIV Care Collaborative for Underserved Populations in the United States.

Merck & Co. also announced the first five partnership and inaugural class of fellows for newly formed Richard T. Clark Fellowship program, with PSI, a global nonprofit organized working to improve the health of people in the developing world. The program aims to strengthen the capability and reach of charitable organizations focused on improving access to health services and health outcomes.

Roche supported the “Roche Continents” program at the Salzburg Festival. The program invited 100 students from Europe to discover the role of innovation in the arts and science during a progam of workshops, discussions, and concert series.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
44%
Facility/environment problems
0%
Process development problems
11%
Production equipment downtime
11%
Raw material supply problems
11%
Regulatory restrictions
0%
Business decisions to limit production
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Patent Settlements Become More Risky
Praise and Perils for Biotechnology Patent Policy
Risk-Mitigation Strategies in Drug Manufacturing for Emerging Markets
Quality Focus: Ensuring Raw Material Transparency
Advertising of Prescription Drugs  Keeping it Honest and Balanced
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here